Teva Asks Fed. Circ. To Examine $177M Verdict Reversal
Teva Pharmaceuticals has urged the Federal Circuit to reverse a Massachusetts federal judge's decision to toss out a $176.5 million migraine drug patent infringement verdict in its favor against Eli Lilly...To view the full article, register now.
Already a subscriber? Click here to view full article